Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer Publisher



Modarres MP1 ; Habibi MA2, 3 ; Pashaei MR4 ; Mohammadpour Y5 ; Jazi K3 ; Ahmadpour S4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Gastroentrology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, Iran
  2. 2. Iranian Tissue Bank and Research Center, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
  3. 3. Student Research Committee, Qom University of Medical Sciences, Qom, Iran
  4. 4. Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran
  5. 5. School of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Source: Current Cancer Therapy Reviews Published:2025


Abstract

Colorectal cancer (CRC) is a commonly diagnosed cancer responsible for numerous deaths worldwide. In recent decades, technological advances implicated in considering the molecular pathways underlying CRC pathogenesis. Several investigations have identified various mechanisms involved in CRC and have paved the way for new therapeutics and early diagnosis. Gut microbiome play a crucial role in intestinal inflammation and can be associated with colitis colorectal cancer. In this review, we narrated the role of the microbiome population and their metabolome profile as a new screening method for early detection of CRC. © 2025 Bentham Science Publishers.
Other Related Docs
23. The Microbiome in Precision Medicine: A New Approach to Cancer Treatment, Journal of Mazandaran University of Medical Sciences (2021)
24. Our Little Friends With Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders, Endocrine# Metabolic and Immune Disorders - Drug Targets (2020)
26. Gut Microbiota and Covid-19: A Systematic Review, Health Science Reports (2023)
35. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer, International Archives of Allergy and Immunology (2022)